Literature DB >> 32056692

Automated radiosynthesis of 68Ga for large-scale routine production using 68Zn pressed target.

Aiman H Alnahwi1, Sébastien Tremblay1, Samia Ait-Mohand1, Jean-François Beaudoin2, Brigitte Guérin3.   

Abstract

Gallium-68 (68Ga) has attracted increasing interest in recent years due to the expanding clinical applications of 68Ga-based radiopharmaceuticals (Rahbar et al., 2017). 68Ga is mainly produced via 68Ge/68Ga generators that are limited in yield by the 68Ge activity (typically up to 1.85 GBq at calibration time). With the increased-demand of 68Ga in nuclear medicine for positron emission tomography (PET) imaging, there is a need for more efficient and robust production methods to obtain larger amounts of [68Ga]GaCl3 with high radionuclidic and radiochemical purity and apparent molar activity (AMA) for facilitating the distribution of 68Ga-based radiopharmaceuticals. The objectives of this study were to develop a fast and efficient process for the preparation of 68Zn-based solid targets and to optimize the critical parameters for the automated radiosynthesis of [68Ga]GaCl3 for large-scale routine production.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  (68)Zn-pressed target; Automated cassette-based module; Cyclotron/proton irradiation; Magnetic target carrier

Year:  2019        PMID: 32056692     DOI: 10.1016/j.apradiso.2019.109014

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  2 in total

Review 1.  Good practices for 68Ga radiopharmaceutical production.

Authors:  Bryce J B Nelson; Jan D Andersson; Frank Wuest; Sarah Spreckelmeyer
Journal:  EJNMMI Radiopharm Chem       Date:  2022-10-22

2.  The Triple-Tracer strategy against Metastatic PrOstate cancer (3TMPO) study protocol.

Authors:  Frédéric Pouliot; Jean-Mathieu Beauregard; Fred Saad; Dominique Trudel; Patrick O Richard; Éric Turcotte; Étienne Rousseau; Stephan Probst; Wassim Kassouf; Maurice Anidjar; Félix Camirand Lemyre; Guillaume F Bouvet; Bertrand Neveu; Amélie Tétu; Brigitte Guérin
Journal:  BJU Int       Date:  2021-11-11       Impact factor: 5.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.